Martin Bernhardt

Martin BERNHARDT is Economic and Social Scientist by training, with specialisation in Pharmacoeconomics. He is since May 2010 Vice-President International Institutions, Sanofi Group, in charge of the relations with the World Health Organization, the World Intellectual Property Organization and other global institutions. He is chair of an internal working group on Non-Communicable Diseases, co-chair of the NCD Alliance Supporters Group and chair of the IFPMA Workstream on Counterfeit Medicines. Before that, he was Public Affairs and Market Access Director, Sanofi-Aventis Switzerland, where he drove a strategic environment analyse for the transformation of the affiliate.

Before joining the pharmaceutical industry, he led research in Health System Science with the Laboratory of Applied Economics and the Medicometry Group, Geneva University. He is still Lecturer at the Pharmacy School, teaching Health Economics and Politics. Among some papers and books, he is co-author of Pour une santé de qualité en Suisse, Paris, Economica, 2003 (reviewed 2008).

Interested in the public and scientific discussion on health systems, he is member of the Swiss Society for Health Policy and was member of the Steering Committee of the International Conference in Systems Science in Health Care.

Work experience

• Sanofi Group VP, Head Global Public Affairs, General Medicines & Emerging Markets
• Sanofi – We are Sanofi - Meet Martin Bernhardt & Tiphaine Lagarde Vice President International Institutions
• University of Geneva Lecturer, Health Economics
• sanofi-aventis (suisse) sa
  • Public Affairs and Market Access Director
  • Public Affairs Deputy

Education

• IMD (International Institute for Management Development) - Business Programs
• Advanced Strategic Management
• Université de Lyon Degree in Pharmacoeconomics
• Université de Genève Master in Social and Economical Sciences Human Geography